表紙
市場調查報告書

單次使用生物反應器市場:成長、動向、預測(2020年∼2025年)

Single-use Bioreactor Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 941576
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
單次使用生物反應器市場:成長、動向、預測(2020年∼2025年) Single-use Bioreactor Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年06月10日內容資訊: 英文
簡介

市場以、製品種類(單次使用生物反應器系統、媒體袋、過濾組件、其他製品)、細胞種類(哺乳類細胞、細菌、酵母、其他細胞種類)、分子種類、終端使用者、地域為基礎進行分割。

市場概要

全球單次使用生物反應器市場,預測期間中預定為15.5%的CAGR。市場的成長要因,包括業界single-use technologies(SUT)的迅速採用、性價比與停機時間的縮短、新製品的發售等。

業界對於單次使用生物反應器使用的傾向,現在被步驟的重要性、製品的價值、及製品的開發與生產時間所影響。這些單次使用生物反應器在醫療領域的需求很高。因此,這些反應爐被製藥公司所採用製造醫藥品,無需對其品質進行任何協商。採用單次使用生物反應器最大優點之一為其彈性。因多劑型施設發展的傾向較強,在同一施設使用,以最短的時間最少的成本生產不同的醫藥品是所追求的目標。

但是,在某個時間點,塑膠製品及單品的消耗品重複成本使得設備投資額上升。固定不鏽鋼機器,在設置及維持管理面上初期費用雖然較高,可知單次使用生物反應器(SUB)的定期的經費變高。另外,為了妥善處理大量不用品,也需要花費高昂成本。

調查範圍

單次使用生物反應器,現在已是生物科技製造施設不可缺的部分。製造技術上延續的製品革新與研究開發費的增加,改善了全體排程,為提供高品質的製品,有主要推進力的機能。因此,從不鏽鋼生物反應器轉變為單次使用生物反應器變得容易許多。單次使用生物反應器,比較安全、簡單、有彈性。也因此,使用增加了。

本報告中,調查了單次使用生物反應器的全球市場,並提供市場概要、製品種類別□細胞種類別□分子種類別□終端使用者別□地域別的市場動向、市場規模的轉變與預測、市場促進□阻礙要因及市場機會的分析、市場佔有、競爭情勢、主要企業檔案資料等等情報。

目次

第1章 導論

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 執行摘要

第4章 市場力學

  • 市場概要
  • 市場成長要因
    • 業界別single-use technologies (SUT)的迅速採用
    • 性價比與停機時間的縮短
    • 新製品的發售
  • 市場的阻礙要因
    • 高昂的經常性費用
    • 滿足適合製造基準的基準問題
  • 波特五力分析

第5章 市場細分化

  • 製品種類別
    • 單次使用生物反應器系統
    • 媒體袋
    • 過濾組件
    • 其他製品
  • 細胞種類別
    • 哺乳動物細胞
    • 細菌
    • 酵母
    • 其他的細胞型
  • 分子種類別
    • 疫苗
    • 單株抗體
    • 幹細胞
    • 遺傳重組蛋白質
    • 其他的分子種類
  • 終端使用者別
    • 製藥及生物技術醫藥品產業
    • 受託調查機關(CRO)
    • 其他終端使用者
  • 地域別
    • 北美
    • 歐洲
    • 亞洲太平洋
    • 中東□非洲
    • 南美

第6章 競爭情勢

  • 企業檔案
    • ABEC Inc.
    • Celltainer
    • Distek Inc.
    • Eppendorf AG
    • GE Healthcare
    • Merck KGaA
    • OmniBRx Biotechnologies
    • Pall Corporation
    • Sartorius AG
    • Thermo Fisher Scientific
目錄

The Market is Segmented on the basis of Type of Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), Molecule Type, End User, and Geography.

Market Overview

The global single-use bioreactor market is expected to witness a CAGR of 15.5% during the forecast period. Certain factors that are driving the market's growth include rapid adoption of single-use technologies (SUTs) by the industry, cost-effectiveness and lower downtime, and launch of new products.

The inclination of the industry toward using single use bioreactors is currently being influenced by the criticality of the step, the value of the product, and the time for product development and production. These single-use bioreactors are in high demand, from the medical sector. These reactors are thus adopted by the pharmaceutical, companies to manufacture drugs without any negotiations on their quality. One of the biggest advantages of the adoption of single use bioreactors is the flexibility. The increasing trend toward multi drug facilities demands the production of different drugs, using the same facility, in minimum time and with minimum costs.

However, at some point, the capital investment is found to be exceeded by the repetitive cost for plasticware and single-use consumables. So, although fixed stainless steel equipment have high upfront costs in terms of installation and maintenance, the regular recurring expenses for single-use bioreactors (SUBs) is found to be higher. In addition, high costs may be involved in proper waste management of the vast amounts of disposables.

Scope of the Report

Single-use bioreactors, also known as disposable bioreactors, have now become an integral part of the biotechnology manufacturing facilities. Continuous product innovation and increasing R&D expenditure in manufacturing technology act as key drivers in improving the overall process and providing high-quality products. This facilitates the transition from stainless steel bioreactors to single-use bioreactors. Single-use bioreactors are comparatively safe, simple, and flexible. Thus, their usage is increasing.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Adoption of Single-use Technologies (SUTs) by the Industry
    • 4.2.2 Cost Effectiveness and Lower Downtime
    • 4.2.3 Launch of New Products
  • 4.3 Market Restraints
    • 4.3.1 High Regular Recurring Expenses
    • 4.3.2 Issues with Meeting the Standards of Good Manufacturing Practices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Type of Product
    • 5.1.1 Single-use Bioreactor Systems
    • 5.1.2 Media Bags
    • 5.1.3 Filtration Assemblies
    • 5.1.4 Other Products
  • 5.2 Cell Type
    • 5.2.1 Mammalian Cell
    • 5.2.2 Bacteria
    • 5.2.3 Yeast
    • 5.2.4 Other Cell Types
  • 5.3 Molecule Type
    • 5.3.1 Vaccines
    • 5.3.2 Monoclonal Antibodies
    • 5.3.3 Stem Cells
    • 5.3.4 Recombinant Proteins
    • 5.3.5 Other Molecule Types
  • 5.4 End User
    • 5.4.1 Pharmaceutical and Biopharmaceutical Industries
    • 5.4.2 Contract Research Organizations (CRO)
    • 5.4.3 Other End Users
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East & Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ABEC Inc.
    • 6.1.2 Celltainer
    • 6.1.3 Distek Inc.
    • 6.1.4 Eppendorf AG
    • 6.1.5 GE Healthcare
    • 6.1.6 Merck KGaA
    • 6.1.7 OmniBRx Biotechnologies
    • 6.1.8 Pall Corporation
    • 6.1.9 Sartorius AG
    • 6.1.10 Thermo Fisher Scientific